Management of Antithrombotic Therapy after Acute Coronary Syndromes

Antithrombotic therapy is a central component of treatment after acute coronary syndromes. The focus is on antiplatelet therapy, but balancing the benefit with the bleeding risk is still controversial. Clinical research and recommended approaches to management are reviewed.

Automated summary

Antithrombotic therapy is a crucial element in the treatment of acute coronary syndromes, with a focus on antiplatelet therapy. However, balancing the benefits and bleeding risks remains controversial. This review examines clinical research and recommended approaches to management in this area.